Clinicodemographic And Cutaneous Manifestation In Sars Cov-2 Infection
Keywords:
SARS-CoV-2, covid toes, Comorbidities Impact on COVID-19 SeverityAbstract
Introduction: Acute respiratory infections have emerged as a critical public health concern worldwide, with COVID-19, caused by the SARS-CoV-2 virus, being at the forefront. This virus has not only led to significant morbidity and mortality but has also been associated with a range of clinical symptoms that extend beyond the respiratory system.
Aims and Objectives: The primary aim of this study is to investigate the clinic demographic profile and cutaneous manifestation of patients with confirmed SARS-CoV-2 infections.
Materials and Methods: This retrospective observational study was conducted over a period of 13 months, from April 2022 to May 2023, at a tertiary care hospital. A total of 4,762 nasopharyngeal swabs were collected for RT-PCR testing, resulting in 285 confirmed cases of COVID-19. Data regarding demographic details, clinical symptoms, and any skin- related symptoms were systematically gathered through structured telephone interviews conducted with the patients or their caregivers.
Results: The analysis revealed that the mean age of the 285 patients was 36.06 years, with a predominance of male patients (62.5%). The most frequently reported symptoms included fever (96.5%), myalgia (95.4%), and cough (78.6%). Notably, cutaneous manifestations were identified in 5.6 % of the patients, with the urticarial rash being the most prevalent
Downloads
References
Dominguez SR, Robinson CC, Holmes KV. 2009. Detection of four human coronaviruses in respiratory infections in children: A one-year study in Colorado. J Med Virol 81:1597–1604
Dong E, Du H, Gardner L (2020a) An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 20:533–534.
Amit Aggarwal, AbhinavShrivastava, Abhinav Kumar, Adila Ali. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi. Journal of The Association of Physicians of India Vol. 68 July 2020.
Yu X, Sun S, Shi Y, Wang H, Zhao R, Sheng J. SARS‐CoV‐2 viral load in sputum correlates with risk of COVID‐19 progression. Crit Care. 2020;24:170.
Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo C, Fischinger S, Chan A, Flaherty KT, Hall K, Dougan M, Ryan ET, Gillespie E, Chishti R, Li Y, Jilg N, Hanidziar D, Baron RM, Baden L, Tsibris AM, Armstrong KA, Kuritzkes DR, Alter G, Walker BD, Yu X, Li JZ; Massachusetts Consortium for Pathogen Readiness. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020 Oct 30;11(1):5493.
Cardillo L, de Martinis C, Viscardi M, Esposito C, Sannino E, Lucibelli G, Limone A, Pellino S, Anastasio R, Pellicanò R, Baldi L, Galiero G, Fusco G. SARS-CoV-2 quantitative real time PCR and viral loads analysis among asymptomatic and symptomatic patients: an observational study on an outbreak in two nursing facilities in Campania Region (Southern Italy). Infect Agent Cancer. 2021 Jun 22;16(1):45.
Bustos P, Tambley C, Acevedo A, et al. Quantitative detection of SARS‐CoV‐2 RNA in nasopharyngeal samples from infected patients with mild disease. J Med Virol. 2021;93:2439‐244.
Yu F, Yan L, Wang N, et al. Quantitative detection and viral load analysis of SARS‐ CoV‐2 in infected patients. Clin Infect Dis. 2020;71: 793‐798.
Huang Y, Chen S, Yang Z, Guan W, Liu D, Lin Z, Zhang Y, Xu Z, Liu X, Li Y. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients. Am J Respir Crit Care Med. 2020 Jun 1;201(11):1435-1438.
Knudtzen FC, Jensen TG, Lindvig SO, Rasmussen LD, Madsen LW, Hoegh SV, et al. (2021) SARS-CoV-2 viral load as a predictor for disease severity in outpatients and hospitalised patients with COVID-19: A prospective cohort study
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
